AstraZeneca taps outside experts to screen cancer compounds

LONDON (Reuters) – British drugmaker AstraZeneca is deepening its collaboration with academia by roping in more outside researchers to help to find new cancer drugs. Scientists at the Cancer Research UK Paterson Institute for Cancer Research at the University of Manchester will use the company’s compounds as a starting point to hunt for potential new drugs, the partners said on Friday. The company is also, for the first time, inviting external researchers to work on compounds within its own screening facility at Alderley Park in northwest England. …